Javascript must be enabled to continue!
Amyotrophic Lateral Sclerosis
View through CrossRef
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognitive impairment occurs in a significant proportion of those affected. Numerous theories of pathogenesis have been advanced. The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death. Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility. The important observation that genes associated with
ribonucleic acid
(RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years. These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future.
Key concepts:
Amyotrophic lateral sclerosis is a motor system degeneration.
The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry. Disease frequency is lower in populations of mixed ancestry.
Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%. There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia.
Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade.
The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration.
Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.
Title: Amyotrophic Lateral Sclerosis
Description:
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons.
Cognitive impairment occurs in a significant proportion of those affected.
Numerous theories of pathogenesis have been advanced.
The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death.
Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility.
The important observation that genes associated with
ribonucleic acid
(RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years.
These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future.
Key concepts:
Amyotrophic lateral sclerosis is a motor system degeneration.
The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry.
Disease frequency is lower in populations of mixed ancestry.
Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%.
There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia.
Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade.
The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration.
Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.
Related Results
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct
Introduction
Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Clinical features of fatigue in amyotrophic lateral sclerosis
Clinical features of fatigue in amyotrophic lateral sclerosis
Background. Fatigue (athenia) is widely spread among patients with neurological disorders. It substantially reduces patients’ quality of life. Its clinical features and mechanisms ...
Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study
Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study
Background: Caregivers of patients with amyotrophic lateral sclerosis (ALS) may suffer from anxiety, depression, and reduced quality of life (QoL). Our goal was to evaluate the QoL...
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
The review summarizes current data on the role of neuroinflammation and mast cells in the pathogenesis of nervous and mental diseases, such as multiple sclerosis, Alzheimers diseas...
Narrative review based on fingolimod therapy in pediatric MS
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is ...
THE ROLE OF PHYSICAL EXERCISE IN REDUCING INFLAMMATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
THE ROLE OF PHYSICAL EXERCISE IN REDUCING INFLAMMATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
Introduction and Aim: Systemic sclerosis (SSc) is a chronic, progressive disease that leads to multi-organ failure. In its pathogenesis, inflammation plays a significant role, part...
Skin TDP-43 pathology as a candidate biomarker for predicting amyotrophic lateral sclerosis decades prior to motor symptom onset
Skin TDP-43 pathology as a candidate biomarker for predicting amyotrophic lateral sclerosis decades prior to motor symptom onset
Abstract
The recognition that disease-associated proteinopathies can manifest in peripheral organs outside the central nervous system preceding the onset of neurologica...

